Celltrion, Inc. (KRX:068270)
South Korea
· Delayed Price · Currency is KRW 151,900
-6,100 (-3.86%)
Last updated: May 12, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Biopharmaceutical Medicines | 6,070.13B |
Log In |
Log In |
Log In |
Log In |
| Biopharmaceutical Medicines Growth | 224.01% |
Log In |
Log In |
Log In |
Log In |
| Chemical Medicines | 531.39B |
Log In |
Log In |
Log In |
Log In |
| Chemical Medicines Growth | 6.11% |
Log In |
Log In |
Log In |
Log In |
| Other Segments | 5.82B |
Log In |
Log In |
Log In |
Log In |
| Other Segments Growth | 13.25% |
Log In |
Log In |
Log In |
Log In |
| Adjustments to | -3,050.04B |
Log In |
Log In |
Log In |
Log In |
| Adjustments to Growth | 1403.08% |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Biopharmaceutical Medicines Operating Income | 1,199.11B |
Log In |
Log In |
Log In |
Log In |
| Biopharmaceutical Medicines Operating Income Growth | 87.84% |
Log In |
Log In |
Log In |
Log In |
| Chemical Medicines Operating Income | 9.18B |
Log In |
Log In |
Log In |
Log In |
| Chemical Medicines Operating Income Growth | -67.04% |
Log In |
Log In |
Log In |
Log In |
| Other Segments Operating Income | 505.60M |
Log In |
Log In |
Log In |
Log In |
| Other Segments Operating Income Growth | 11.43% |
Log In |
Log In |
Log In |
Log In |
| Adjustments to Operating Income | -716.79B |
Log In |
Log In |
Log In |
Log In |
| Adjustments to Operating Income Growth | 4614.91% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Domestic | 1,554.99B |
Log In |
Log In |
Log In |
Log In |
| Domestic Growth | -26.41% |
Log In |
Log In |
Log In |
Log In |
| Americas | - |
Log In |
Log In |
Log In |
Log In |
| Americas Growth | - |
Log In |
Log In |
Log In |
Log In |
| Asia | 192.46B |
Log In |
Log In |
Log In |
Log In |
| Asia Growth | 204.16% |
Log In |
Log In |
Log In |
Log In |
| Europe | 1,500.81B |
Log In |
Log In |
Log In |
Log In |
| North America | 168.09B |
Log In |
Log In |
Log In |
Log In |
| Central and South America | 140.96B |
Log In |
Log In |
Log In |
Log In |